BioAge Labs, Inc. Cash Flow Statement

Cash Flow Statement Dec2023 Dec2024
Operating Activities
Net Income -53.76M-70.93M
Depreciation and Depletion 0.20M0.20M
Share-based Compensation 3.02M6.98M
Gains from Investment Securities 0.41M1.00M
Cash from Operations -37.36M-51.52M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) 0.20M0.20M
Change in Working Capital
Change in Account Payables -0.39M0.01M
Change in Accured Expenses 3.73M4.63M
Other Working Capital Changes -0.04M12.50M
Investing Activities
Capital Expenditures 0.17M0.37M
Cash from Investing Activities -0.27M-0.37M
Financing Activities
Other financing activities 0.05M0.54M
Cash from Financing Activities 34.94M381.20M
Additional items
Exchange Rate Effect 0.08M
Change in Cash -2.69M329.39M
Beginning Cash Balance 2.69M-329.39M
Free Cash Flow -37.53M-51.89M
Net Cash Flow -2.69M329.31M